These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3286516)

  • 1. Bacterial infections of the skin treated with ciprofloxacin.
    Gorkiewicz-Petkow A; Weuta H; Jablonska S; Petkow L; Bielunska S; Gawkonska M
    Infection; 1988; 16 Suppl 1():S55-6. PubMed ID: 3286516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ciprofloxacin versus ceftazidime in skin and soft tissue infections.
    Thadepalli H; Mathai D; Chuah SK; Bansal MB
    J Chemother; 1989 Feb; 1(1):30-4. PubMed ID: 2656929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind comparison of ciprofloxacin with cefotaxime in the treatment of skin and skin structure infections.
    Pérez-Ruvalcaba JA; Quintero-Pérez NP; Morales-Reyes JJ; Huitrón-Ramírez JA; Rodríguez-Chagollán JJ; Rodríguez-Noriega E
    Am J Med; 1987 Apr; 82(4A):242-6. PubMed ID: 3555042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ciprofloxacin for soft tissue infections.
    Wood MJ; Logan MN
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():159-64. PubMed ID: 3804904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of skin and soft tissue infections with oral ciprofloxacin.
    Fass RJ
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():153-7. PubMed ID: 3804903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ciprofloxacin treatment in bacterial skin infections].
    Mohr CP; Küchmeister B; Reinel D; Ulrich R
    Fortschr Med; 1989 May; 107(16):367-9. PubMed ID: 2737587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effectiveness of ciprofloxacin in bacterial skin infections].
    Meisel C; Blenk H
    Z Hautkr; 1988 Dec; 63(12):1016-22. PubMed ID: 3218288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic antimicrobial therapy in skin and skin structure infections: comparison of temafloxacin and ciprofloxacin.
    Parish LC; Jungkind DL
    Am J Med; 1991 Dec; 91(6A):115S-119S. PubMed ID: 1662880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic treatment of cutaneous infections. A comparative study of ciprofloxacin and cefotaxime.
    Parish LC; Asper R
    Am J Med; 1987 Apr; 82(4A):227-9. PubMed ID: 3555041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ciprofloxacin: an update on clinical experience.
    Arcieri G; Griffith E; Gruenwaldt G; Heyd A; O'Brien B; Becker N; August R
    Am J Med; 1987 Apr; 82(4A):381-6. PubMed ID: 3555063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative, double-blind study of oral ciprofloxacin and intravenous cefotaxime in skin and skin structure infections.
    Ramirez-Ronda CH; Saavedra S; Rivera-Vázquez CR
    Am J Med; 1987 Apr; 82(4A):220-3. PubMed ID: 3555040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral ciprofloxacin vs parenteral cefotaxime in the treatment of difficult skin and skin structure infections. A multicenter trial.
    Gentry LO; Ramirez-Ronda CH; Rodriguez-Noriega E; Thadepalli H; del Rosal PL; Ramirez C
    Arch Intern Med; 1989 Nov; 149(11):2579-83. PubMed ID: 2684078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Symposium "Ciflozin (ciprofloxacin)--a broad-spectrum antibacterial drug"].
    Iakovlev VP
    Antibiot Khimioter; 1992 Mar; 37(3):51. PubMed ID: 1514870
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy, safety, and potential economic benefits of oral ciprofloxacin in the treatment of infections.
    Sanders WE
    Rev Infect Dis; 1988; 10(3):528-43. PubMed ID: 3293158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with ciprofloxacin: analysis of a multicenter study.
    Karimi K
    Indiana Med; 1990 Apr; 83(4):266-9. PubMed ID: 2185309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial infections of the lower urinary tract treated with ciprofloxacin or cefalexin--a comparative study.
    Polubiec A; Weuta H; Stepka K; Ktos K; Strazynska R; Jórasz J
    Infection; 1988; 16 Suppl 1():S62-4. PubMed ID: 3286518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous/oral ciprofloxacin versus intravenous ceftazidime in the treatment of serious gram-negative infections of the skin and skin structure.
    Gentry LO; Koshdel A
    Am J Med; 1989 Nov; 87(5A):132S-135S. PubMed ID: 2686413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciprofloxacin versus cefotaxime in skin and skin structure infections: a double-blind study.
    Ramirez-Ronda C; Saavedra S
    Chemioterapia; 1987 Jun; 6(2 Suppl):432-4. PubMed ID: 3334591
    [No Abstract]   [Full Text] [Related]  

  • 19. Prospective, controlled, randomized non-blind comparison of intravenous/oral ciprofloxacin with intravenous ceftazidime in the treatment of skin or soft-tissue infections.
    Dominguez J; Palma F; Vega ME; Magaña JL; Ortiz G; Teresa-Hojyo M; Dominguez L
    Am J Med; 1989 Nov; 87(5A):136S-137S. PubMed ID: 2686414
    [No Abstract]   [Full Text] [Related]  

  • 20. A survey of clinical experience with ciprofloxacin, a new quinolone antimicrobial.
    Arcieri G; Griffith E; Gruenwaldt G; Heyd A; O'Brien B; Screen P; Becker N; August R
    J Clin Pharmacol; 1988 Feb; 28(2):179-89. PubMed ID: 3360968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.